[{"Assets_0_FY_USD":401586000.0,"CommonStockSharesOutstanding_0_FY_shares":50882856.0,"NetIncomeLoss_4_FY_USD":-60923000.0,"NetIncomeLoss_1_FY_USD":-17859000.0,"StockholdersEquity_0_FY_USD":80037000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":58634000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":50360000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":58634000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":50360000.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170322"}]